Credit Suisse’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.05M | Hold |
120,555
| – | – | ﹤0.01% | 2231 |
|
|
2023
Q4 | $790K | Buy |
120,555
+8,197
| +7% | +$53.7K | ﹤0.01% | 2480 |
|
|
2023
Q3 | $1.12M | Sell |
112,358
-3,990
| -3% | -$39.9K | ﹤0.01% | 2222 |
|
|
2023
Q2 | $1.45M | Buy |
116,348
+4,158
| +4% | +$51.7K | ﹤0.01% | 2123 |
|
|
2023
Q1 | $1.57M | Buy |
112,190
+3,991
| +4% | +$55.9K | ﹤0.01% | 2006 |
|
|
2022
Q4 | $1.55M | Sell |
108,199
-1,182
| -1% | -$16.9K | ﹤0.01% | 2021 |
|
|
2022
Q3 | $2.79M | Buy |
109,381
+3,181
| +3% | +$81.2K | ﹤0.01% | 1612 |
|
|
2022
Q2 | $3.02M | Sell |
106,200
-36,683
| -26% | -$1.04M | ﹤0.01% | 1617 |
|
|
2022
Q1 | $5.04M | Buy |
142,883
+47,223
| +49% | +$1.67M | ﹤0.01% | 1425 |
|
|
2021
Q4 | $4.01M | Sell |
95,660
-142,350
| -60% | -$5.97M | ﹤0.01% | 1663 |
|
|
2021
Q3 | $11.7M | Buy |
238,010
+171,725
| +259% | +$8.43M | 0.01% | 1052 |
|
|
2021
Q2 | $2.77M | Buy |
+66,285
| New | +$2.77M | ﹤0.01% | 1953 |
|